Cyprotex (LSE:CRX) Dividend Payout Ratio : 0.00 (As of Jun. 2016)

View and export this data going back to 2002. Start your Free Trial

What is Cyprotex Dividend Payout Ratio?

Cyprotex's dividend payout ratio for the months ended in Jun. 2016 was 0.00.

The historical rank and industry rank for Cyprotex's Dividend Payout Ratio or its related term are showing as below:

LSE:CRX's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.435
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-05-10), the Dividend Yield % of Cyprotex is 0.00%.

Cyprotex's Dividends per Share for the months ended in Jun. 2016 was £0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Cyprotex Dividend Payout Ratio Historical Data

The historical data trend for Cyprotex's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyprotex Dividend Payout Ratio Chart

Cyprotex Annual Data

Trend

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dividend Payout Ratio

Get a 7-Day Free Trial

Cyprotex Semi-Annual Data
	Dec06	Jun07	Dec07	Jun08	Dec08	Jun09	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Cyprotex's Dividend Payout Ratio

For the Biotechnology subindustry, Cyprotex's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cyprotex's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cyprotex's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Cyprotex's Dividend Payout Ratio falls into.

Cyprotex Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Cyprotex's Dividend Payout Ratio for the fiscal year that ended in Dec. 2015 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2015 )	/	EPS without NRI (A: Dec. 2015 )
	=	0	/	-0.29
	=	N/A

Cyprotex's Dividend Payout Ratio for the quarter that ended in Jun. 2016 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jun. 2016 )	/	EPS without NRI (Q: Jun. 2016 )
	=	0	/	0.13
	=	0.00

Cyprotex (LSE:CRX) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Cyprotex Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Cyprotex's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Cyprotex (LSE:CRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cyprotex PLC (LSE:CRX) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.cyprotex.com

Cyprotex PLC was incorporated on October 25, 2001. The Company together with its subsidiaries, provides in vitro and in silico ADMET and PK (absorption, distribution, metabolism, excretion, toxicity and pharmacokinetics) information to a number of different industries including the Pharmaceutical, Biotechnology, Cosmetic, Personal Care, Agrochemical, Chemical Industries and Academia. It provides a range of ADME Tox contract research services, which includes ADME screening, Customized ADME assays, Genomic ADME, In silico pharmacokinetics modeling and In vitro toxicology. It also offers integrated drug discovery services in collaboration with Sygnature Discovery and physicochemical profiling services in collaboration with Sirius Analytical. The Company operates in North America, Mainland Europe and United Kingdom.

Cyprotex (LSE:CRX) Headlines

No Headlines